Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Goyal, A; Blazing, M

Published Date

  • October 2005

Published In

Volume / Issue

  • 150 / 4

Start / End Page

  • 650 - 651

PubMed ID

  • 16209959

Pubmed Central ID

  • 16209959

Electronic International Standard Serial Number (EISSN)

  • 1097-6744

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2005.08.001

Language

  • eng

Conference Location

  • United States